This is a continued contract transferred from ACC - jcrd (DOD) to HHS/aspr/barda/CMA for covid-19 vaccinations for the 2022 fall vaccine campaign. The original contract number is W58P0522C0016.

Ended Definitive Contract Awarded Last action

Contract number
75A50122C00055
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
  • W58P0522R0007 Solicitation number
Contract value 0% obligated
  • $0.00 Current, with exercised options
  • $7,837,399,989.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 · No-cost time extension under clins 0002 & 0003 $0
Supplemental Agreement for work within scope P00006 · Provides mechanism for CO to authorize disposal and destruction of vaccine at no cost as consideration for return of storage space under clin 0002 $0
Other Administrative Action P00005 · This modification provides a 4-month NCE to clins 0002 and 0003 $0
Other Administrative Action P00004 · This modification provides a 30-day NCE to clins 0002 and 0003 $0
Other Administrative Action P00003 · This modification provides a 30-day NCE to clins 0002 and 0003 and changes those clins to indicate HHS is solely responsible for the admin of those clins. $0
Supplemental Agreement for work within scope P00002 · This modification is to update the SOW, update quantities, update cost per dose, and update h.20 $0
Modification $0
Supplemental Agreement for work within scope P00001 · This modification is to add HHS terms and conditions to the continued contract transferred from ACC-jcrd 75A50122C0017 $0

About this award

Written by GovTribe AI ·

This definitive contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Moderna US, Inc. for COVID-19 vaccinations in support of the 2022 Fall Vaccine Campaign. The $7.8 billion firm fixed price contract is a transfer from the original awarding agency, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, and represents continuation of vaccine production and delivery efforts. As the prime contractor, Moderna US, Inc. will provide its mRNA-1273 coronavirus vaccine from its Cambridge, Massachusetts facility over a 15-month period ending in February 2024. The contract builds upon previous vaccine procurements and distributions managed by the Biomedical Advanced Research and Development Authority to support preparedness and response initiatives.

Quick answers

Who was awarded contract 75A50122C00055?

75A50122C00055 was awarded to Moderna US, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on October 1, 2022.

How much is contract 75A50122C00055 worth?

The government has obligated $0 on 75A50122C00055. Its potential value, with all options, is $7,837,399,989.

Was contract 75A50122C00055 competed?

The extent of competition for 75A50122C00055 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login